Tempus ECG-AF vs Tyto Stethoscope
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify elderly patients (65+) at high risk of developing new-onset atrial fibrillation within the next year, utilizing existing 12-lead ECG data. This tool is ideal for integrating into cardiology or geriatrics workflows to enhance early detection and enable timely follow-up for AF risk management in a clinical setting.
View Tempus ECG-AF →Choose Tyto Stethoscope if…
Choose Tyto Stethoscope if you need a versatile solution for conducting comprehensive remote physical examinations and vital sign measurements during virtual patient visits. This tool is best suited for telehealth platforms in family medicine, internal medicine, or pediatrics, where clinicians require the ability to remotely assess heart, lung, ear, throat, and skin conditions with AI-powered assistance.
View Tyto Stethoscope →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Tyto Stethoscope |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tyto StethoscopeTyto Stethoscope offers a handheld device with a mobile application and guided examination processes, making it highly accessible and user-friendly for remote medical exams. While Tempus ECG-AF integrates into existing systems, Tyto's direct user interaction and guided workflows suggest a more intuitive experience for its intended use case.
Clinical Value
Tempus ECG-AFTempus ECG-AF provides a highly specific and impactful clinical value by using an FDA-cleared AI to predict the risk of AF within 12 months from a standard ECG, enabling earlier intervention for a serious condition. While Tyto Stethoscope offers broad remote diagnostic capabilities, Tempus's predictive AI for a critical cardiac condition represents a significant advancement in proactive patient care.
Pricing & Value
Tempus ECG-AFTempus ECG-AF has clear CMS reimbursement codes (CPT 0764T and CPT 0765T) and a specified Medicare rate of $128.90, offering transparent financial viability for healthcare providers. In contrast, Tyto Stethoscope's professional version includes an undisclosed monthly subscription fee in addition to a $999 upfront cost, making its total enterprise cost less transparent.
Enterprise Readiness
Tempus ECG-AFBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs. Tempus ECG-AF is designed as a software solution integrated into healthcare facility systems, which is crucial for seamless workflow adoption within established IT infrastructures. Tyto Stethoscope, while cloud-based and suitable for telehealth, might require more standalone adoption rather than deep integration into core hospital systems.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates significant innovation by applying AI to standard 12-lead ECGs to predict the future risk of Atrial Fibrillation, moving towards proactive and preventative medicine. While Tyto Stethoscope innovates in comprehensive remote examination, Tempus's predictive AI for a critical condition from existing data is a novel and impactful application.
Support & Docs
TieThe provided structured facts do not contain specific information regarding the support and documentation for either tool. Without further detailed comparative information from publicly available sources, it is not possible to definitively distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Tyto Stethoscope |
|---|---|---|
| Tool Name | Tempus ECG-AF | Tyto Stethoscope |
| Company | Tempus AI, Inc. | Tyto Care |
| Description | Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | TytoCare provides an AI-powered, all-in-one modular device and platform for remote medical exams, enabling comprehensive virtual visits for heart, lungs, ears, throat, and skin, along with vital sign measurements. |
| Primary Category | Cardiology AI | Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM) |
| Key Features | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery; Results interpreted in conjunction with other diagnostic information and clinical history; Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems; Trained on over 1.5 million ECGs from over 500,000 patients | Remote physical exams (heart, lungs, ears, throat, skin, abdomen); Measures heart rate and body temperature; High-quality digital sounds, images, and video capture; Guided examination process with on-device and in-app instructions; Supports live and asynchronous telehealth workflows; AI-powered diagnostics and clinical decision support (e.g., lung sound identification); HIPAA-compliant cloud storage and encrypted data transmission; Mobile application for iOS and Android devices |
| Specialties | Cardiology, Geriatrics, Internal Medicine | Family Medicine, Internal Medicine, Pediatrics |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Tyto Stethoscope.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-AF or Tyto Stethoscope
Backers
Who funded each tool's parent company.